These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16805389)

  • 1. [Modulation of reactivity of cyclic adenosine monophosphate phosphodiesterase under the effect of pyridinecarboxylic acid derivatives and Pt(IV) metal complexes on their basis].
    Tat'ianenko LV; Bogdanov GN; Dobrokhotova OV; Fadeev MA; Fedorov BS
    Biomed Khim; 2006; 52(2):174-9. PubMed ID: 16805389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro.
    Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y
    Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory action of newly synthesized 1,3-dimethylxanthine derivatives on the 3',5'-cyclic AMP phosphodiesterase activity of the homogenates of various tissues].
    Staneva D; Bogoslovova T; Pankova A
    Eksp Med Morfol; 1980; 19(3):154-9. PubMed ID: 6252004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of some phosphodiesterase inhibitors on two different preparations of adenosine 3',5'-monophosphate phosphodiesterase.
    Du Moulin A; Schultz J
    Experientia; 1975 Aug; 31(8):883-4. PubMed ID: 169139
    [No Abstract]   [Full Text] [Related]  

  • 5. The interaction of 4-alkyl derivatives of 2,6,7-trioxa-1-phosphabicyclo [2,2,2] octanes with cyclic adenosine 3',5'-monophosphate phosphodiesterase, and with cyclic adenosine 3',5'-monophosphate binding proteins.
    Coult DB; Wilkinson RG
    Biochem Pharmacol; 1977 May; 26(9):887-9. PubMed ID: 193519
    [No Abstract]   [Full Text] [Related]  

  • 6. 8-Substituted derivatives of adenosine 3',5'-cyclic phosphate require an unsubstituted 2'-hydroxyl group in the ribo configuration for biological activity.
    Khwaja TA; Boswell KH; Robins RK; Miller JP
    Biochemistry; 1975 Sep; 14(19):4238-44. PubMed ID: 170958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver.
    Hoshi Y
    Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of imidazole compounds on the activity of adenosine-3', 5'-monophosphoric acid phosphodiesterase].
    Lunts VIa
    Biull Eksp Biol Med; 1976 Sep; 82(9):1055-9. PubMed ID: 186138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adenosine cyclic-3',5'-monophosphate phosphodiesterase in hepatomas with different growth rates].
    Pavlova VM; Bogdanov GN; Vatolkina OE; Libinzon RE
    Eksp Onkol; 1984; 6(4):28-30. PubMed ID: 6094146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by nicotinic acid [proceedings].
    Saeed SA; Butt NM; Lovely JR; Collier HO
    Biochem Soc Trans; 1979 Oct; 7(5):1042-4. PubMed ID: 229022
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical stimulation by 1-methyl-3-isobutylxanthine of rat liver cyclic AMP phosphodiesterase activity.
    Erneux C; Miot F; Boeynaems JM; Dumont JE
    FEBS Lett; 1982 Jun; 142(2):251-4. PubMed ID: 6179796
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of benzimidazole derivatives and levamisole (phenylimidothiazole) on cyclic 3':5'-AMP phosphodiesterase from pig brain].
    Kochetkova MN; Ozeretskovskaia NN
    Biokhimiia; 1982 Jul; 47(7):1208-11. PubMed ID: 6288125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
    Shchekoldina TG; Vatolkina OE; Libinzon RE
    Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition of platelet aggregation and cyclic nucleotide phosphodiesterase (specifically cyclAMP) by 3-hydroxypyridine derivatives].
    Kagan VE; Polianskiĭ NB; Muranov KO; Shvedova AA; Smirnov LD
    Biull Eksp Biol Med; 1984 Apr; 97(4):416-8. PubMed ID: 6202339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of rat heart and brain cyclic 3',5'-adenosine monophosphate phosphodiesterase under the influence of neurohormone "C"].
    Galoian AA; Gurvits BIa; Pogosian MA
    Vopr Biokhim Mozga; 1976; 11():89-96. PubMed ID: 203105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
    Tunitskaia VL; Itkes AV; Kochetkova MN; Severin ES
    Biokhimiia; 1983 Oct; 48(10):1721-5. PubMed ID: 6315087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New imidazo(1,2-a)pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities.
    Vitse O; Laurent F; Pocock TM; Bénézech V; Zanik L; Elliott KR; Subra G; Portet K; Bompart J; Chapat JP; Small RC; Michel A; Bonnet PA
    Bioorg Med Chem; 1999 Jun; 7(6):1059-65. PubMed ID: 10428374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
    Levin RM; Weiss B
    Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enaminones 9. Further studies on the anticonvulsant activity and potential type IV phosphodiesterase inhibitory activity of substituted vinylic benzamides.
    Anderson AJ; Nicholson JM; Bakare O; Butcher RJ; Wilson TL; Scott KR
    Bioorg Med Chem; 2006 Feb; 14(4):997-1006. PubMed ID: 16219468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.